Inquiry Basket
CAS No.: 1313034-29-5
Cat No.: BADC-01584
4.5 
Tert-butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-oxa-9-azabicyclo[3.3.1]non-6-ene-9-carboxylate is a biomedical product used for the drug development of certain diseases. It exhibits potential in targeting specific protein receptors implicated in various drug-resistant cancers, making it a promising candidate for anticancer therapies.
![Tert-butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-oxa-9-azabicyclo[3.3.1]non-6-ene-9-carboxylate](https://resource.bocsci.com/structure/1313034-29-5.gif)
Structure of 1313034-29-5
* For research and manufacturing use only. We do not sell to patients.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
| Catalog | Product Name | CAS | Inquiry |
|---|---|---|---|
| BADC-00393 | tert-butyl 1-(4-formylphenyl)-1-oxo-5,8,11-trioxa-2-azatridecan-13-oate | 1007215-94-2 | |
| BADC-00394 | tert-butyl 1-(4-formylphenyl)-1-oxo-5,8,11,14,17,20,23,26,29,32,35-undecaoxa-2-azaheptatriacontan-37-ylcarbamate | 1245813-70-0 | |
| BADC-01551 | tert-Butyl 30-amino-4-oxo-7,10,13,16,19,22,25,28-octaoxa-2,3-diazatriacontan-1-oate | 1334169-96-8 | |
| BADC-01563 | tert-Butyl 1-oxo-3,6,9,12-tetraoxapentadecan-15-oate | 1415329-20-2 | |
| BADC-01561 | tert-Butyl 14-(tosyloxy)-3,6,9,12-tetraoxatetradecan-1-oate | 169751-73-9 | |
| BADC-01553 | tert-Butyl (2-(2-(2-(2-(4-(6-methyl-1,2,4,5-tetrazin-3-yl)phenoxy)ethoxy)ethoxy)ethoxy)ethyl)carbamate | 2194563-84-1 | |
| BADC-01580 | Tert-butyl 9-oxo-3-azabicyclo[3.3.1]nonane-3-carboxylate | 512822-34-3 | |
| BADC-01921 | tert-Butyl Hydrogen Hexadecanedioate | 843666-27-3 | |
| BADC-01620 | tert-Butyl (26-(4-(aminomethyl)-1H-1,2,3-triazol-1-yl)-3,6,9,12,15,18,21,24-octaoxahexacosyl)carbamate |
Tert-butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-oxa-9-azabicyclo[3.3.1]non-6-ene-9-carboxylate
Required fields are marked with *
Tert-butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-oxa-9-azabicyclo[3.3.1]non-6-ene-9-carboxylate
Required fields are marked with *
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.
